Naomi moved to Australia from the UK in 2007 after completing a BSc in Psychology. In 2009 she begun studying for her PhD, whilst also working part time as a research assistant on a number of clinical trials of natural medicine, alcohol and other drugs, and their effects on cognition and brain function. After working as the Clinical Trials Coordinator for the Centre for Human Psychopharmacology at Swinburne University for over three years, Naomi joined the Tong Group at the Doherty Institute to manage the ASCOT trial, which is investigating potential treatments for COVID-19.
Naomi has published four peer-reviewed research papers and three book chapters, as well as attending conferences in the USA, Spain and across Australia. Over the course of her career she has worked on over 30 clinical trials of natural medicines, diet and exercise, alcohol, and illicit drugs, investigating their effects on the brain and behaviour. She is an adjunct research fellow at Swinburne University, and is Chair of the Data and Safety Monitoring Board for the MedWalk trial, investigating the effects of Mediterranean diet and a walking intervention in elderly participants in independent living facilities.
Steve’s group conducts clinical trials to optimise the treatment of infections due to methicillin-resistant Staphylococcus aureus and other bacterial pathogens. He also investigates the epidemiology and genomics of streptococcal infections, hepatitis B, influenza, and antimicrobial resistance in Australian Indigenous communities.